REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation--The RELIEF study.

Coleman, Craig I; Antz, Matthias; Ehlken, Birgit; Evers, Thomas

Coleman, Craig I; Antz, Matthias; Ehlken, Birgit; Evers, Thomas.

Affiliation

Coleman CI; University of Connecticut School of Pharmacy, Storrs, CT, USA. Electronic address: craig.coleman@hhchealth.org.
Antz M; Hospital Oldenburg, Department of Cardiology, Oldenburg, Germany.
Ehlken B; IMS Health, Munich, Germany.
Evers T; Bayer Pharma AG, Wuppertal, Germany.

Int J Cardiol ; 203: 882-4, 2016 Jan 15.

Article in En | MEDLINE | ID: mdl-26605688

Subject(s)

Atrial Fibrillation/complications; Factor Xa Inhibitors/therapeutic use; Stroke/prevention & control; Aged; Female; Humans; Male; Stroke/etiology

Key words

Anticoagulant; Non-valvular atrial fibrillation; Rivaroxaban; Stroke; Vitamin k antagonist

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke / Factor Xa Inhibitors Type of study: Etiology_studies Limits: Aged / Female / Humans / Male Language: En Journal: Int J Cardiol Year: 2016 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google